ATE528287T1 - Nicht peptidische rgd-analoga mit adhäsions-, migrations- und proliferationshemmender wirkung - Google Patents

Nicht peptidische rgd-analoga mit adhäsions-, migrations- und proliferationshemmender wirkung

Info

Publication number
ATE528287T1
ATE528287T1 AT02708622T AT02708622T ATE528287T1 AT E528287 T1 ATE528287 T1 AT E528287T1 AT 02708622 T AT02708622 T AT 02708622T AT 02708622 T AT02708622 T AT 02708622T AT E528287 T1 ATE528287 T1 AT E528287T1
Authority
AT
Austria
Prior art keywords
adhesion
migration
proliferation effects
peptidic
proliferation
Prior art date
Application number
AT02708622T
Other languages
English (en)
Inventor
Antonio Facchiano
Francesco Facchiano
Ivan Rossi
Rita Casadio
Original Assignee
Provincia Italiana Della Congregazione Dei Figli Dell Immacolata Concezione Istituto Dermopatico Del
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Provincia Italiana Della Congregazione Dei Figli Dell Immacolata Concezione Istituto Dermopatico Del filed Critical Provincia Italiana Della Congregazione Dei Figli Dell Immacolata Concezione Istituto Dermopatico Del
Application granted granted Critical
Publication of ATE528287T1 publication Critical patent/ATE528287T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT02708622T 2001-02-21 2002-02-19 Nicht peptidische rgd-analoga mit adhäsions-, migrations- und proliferationshemmender wirkung ATE528287T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001RM000089A ITRM20010089A1 (it) 2001-02-21 2001-02-21 Molecole non peptidiche analoghe al peptide rgd con effetto inibitorio sulla adesione, la migrazione e la proliferazione cellulare.
PCT/IT2002/000099 WO2002066421A1 (en) 2001-02-21 2002-02-19 Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects

Publications (1)

Publication Number Publication Date
ATE528287T1 true ATE528287T1 (de) 2011-10-15

Family

ID=11455245

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02708622T ATE528287T1 (de) 2001-02-21 2002-02-19 Nicht peptidische rgd-analoga mit adhäsions-, migrations- und proliferationshemmender wirkung

Country Status (7)

Country Link
US (1) US6627769B2 (de)
EP (1) EP1366022B1 (de)
JP (1) JP2004527488A (de)
AT (1) ATE528287T1 (de)
AU (1) AU2002242948B2 (de)
IT (1) ITRM20010089A1 (de)
WO (1) WO2002066421A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004094457A2 (en) * 2003-04-16 2004-11-04 Arizona Board Of Regents, Acting For And On Behalf Of, Arizona State University Stable rgd peptidomimetic composition
US20060029544A1 (en) * 2004-08-06 2006-02-09 The Regents Of The University Of California Office Of Technology Transfer Receptor-binding cyclic peptides and methods of use
WO2017040037A1 (en) 2015-08-31 2017-03-09 Dow Global Technologies Llc Methods of preparing vinylidene chloride polymer compositions
WO2017040036A1 (en) 2015-08-31 2017-03-09 Dow Global Technologies Llc Vinylidene chloride polymer compositions and articles comprising the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992013552A1 (en) 1991-02-05 1992-08-20 Smithkline Beecham Corporation Anti-aggregatory peptides containing an aromatic ester or amide
US5352667A (en) 1991-11-22 1994-10-04 Ofer Lider Non-peptidic surrogates of the Arg-Gly-Asp sequence and pharmaceutical compositions comprising them
JP3274225B2 (ja) 1992-06-03 2002-04-15 富士写真フイルム株式会社 アミノ酸誘導体及びその用途
US5599984A (en) * 1994-01-21 1997-02-04 The Picower Institute For Medical Research Guanylhydrazones and their use to treat inflammatory conditions

Also Published As

Publication number Publication date
EP1366022B1 (de) 2011-10-12
JP2004527488A (ja) 2004-09-09
WO2002066421A1 (en) 2002-08-29
AU2002242948B2 (en) 2007-12-20
ITRM20010089A1 (it) 2002-08-21
ITRM20010089A0 (it) 2001-02-21
US20020119932A1 (en) 2002-08-29
EP1366022A1 (de) 2003-12-03
US6627769B2 (en) 2003-09-30

Similar Documents

Publication Publication Date Title
AR036196A1 (es) Agentes de contraste multimericos dirigidos a base de peptidos
EE05472B1 (et) Fumaarhappeamiidide kasutamine ravimina
DK1423419T3 (da) Hybrid- og tandemekspression af Neisseria-proteiner
EP1875924A3 (de) RGD-angereicherte gelatineähnliche Proteine zur Verhinderung der Blutplättchenaggregation
DE69434181D1 (de) Therapeutische Peptid Derivate
DE60131021D1 (de) Klebstoffzusammensetzungen mit selbstorganisierenden molekülen, klebstoffe, gegenstände und verfahren
TR200200252T2 (tr) Şimerik polipeptidler, bunların üretimi için yöntem ve kullanımı
IT1196500B (it) Derivati dell'acido malonico e metodi per la loro sintesi
DE60218064D1 (de) Neues peptid mit angiotensinkonvertase hemmender wirkung
NO982715D0 (no) Endotel celle-proliferasjonsinhibitor og fremgangsmÕte for anvendelse
ATE528287T1 (de) Nicht peptidische rgd-analoga mit adhäsions-, migrations- und proliferationshemmender wirkung
ES2421720T3 (es) Homólogos del factor de necrosis tumoral y ácidos nucleicos que los codifican
HRP20050371B1 (hr) Oblik za primjenu farmaceutiski djelatnih peptida s produljenim oslobađanjem djelatnog sastojka i postupak za njihovu proizvodnju
DE50113975D1 (de) Peptid- und peptidmimetikakonjugate mit integrin-inhibitor-eigenschaften
ATE242202T1 (de) Peptide
AP2002002584A0 (en) Protease Inhibitors And Thier Pharmaceutical Uses.
DK1180094T3 (da) Kondenserede polycykliske aminosyrer som farmaceutiske midler
DE60044945D1 (de) Auf scf peptid basiertes basolaterales sortiersignal und inhibitoren dafür
IT1226552B (it) Peptidi immunostimolanti.
DE60032600D1 (de) Spermin:peptidhaltige tenside
WO2002008202A3 (en) Alpha amino acid derivatives--inhibitors of leukocyte adhesion mediated by vla-4
AU1521500A (en) Inhibition of angiogenesis by peptide analogs of high molecular weight kininogendomain
ATE173022T1 (de) Produktion von peptid-amiden
DE69211990D1 (de) Substituierte benzhydrylamine als anknüpfungsmoleküle bei der festphasenpeptidsynthese
TW200505945A (en) Oligopeptides

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties